NASDAQ
Edgewise Therapeutics, Inc. (EWTX) has a free cash flow growth of -11.44% as of Friday, May 29, 2026. This represents a 8.18% decrease compared to its 12-month average of -10.58%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.